Government urged to devise post-KORUS FTA steps

Published: 2011-12-08 07:00:00

Updated: 2011-12-08 07:00:00

The government needs to assess the damage that its free trade deal with the U.S. would cause in pharmaceutical sector in the future and map out proper countermeasures, industry official said.

The ruling Grand national Party and the opposition parties have been in conflict the investor-state di...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK